CL2019000198A1 - Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración. - Google Patents
Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración.Info
- Publication number
- CL2019000198A1 CL2019000198A1 CL2019000198A CL2019000198A CL2019000198A1 CL 2019000198 A1 CL2019000198 A1 CL 2019000198A1 CL 2019000198 A CL2019000198 A CL 2019000198A CL 2019000198 A CL2019000198 A CL 2019000198A CL 2019000198 A1 CL2019000198 A1 CL 2019000198A1
- Authority
- CL
- Chile
- Prior art keywords
- compositions
- methods
- cannabis
- elaboration
- tablets
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000009472 formulation Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 240000004308 marijuana Species 0.000 title 1
- 229930003827 cannabinoid Natural products 0.000 abstract 2
- 239000003557 cannabinoid Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- -1 LOADS Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 229940065144 cannabinoids Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
COMPOSICIONES QUE COMPRENDEN UN ACEITE QUE TIENE POR LO MENOS UN CANNABINOIDE Y POR LO MENOS UN POLVO SÓLIDO Y MÉTODOS PARA ELABORAR Y USANDO LAS MISMAS. LAS COMPOSICIONES SON APROPIADAS PARA HACER COMPRIMIDOS QUE CONTIENEN CANNABINOIDES PRENSANDO UNA COMPOSICIÓN DE LA PRESENTE INVENCIÓN CON UNO O MÁS AGENTES DE FORMULACIÓN, COMO POR EJEMPLO AGLUTINANTES, CARGAS, AGENTES PARA AUMENTAR EL VOLUMEN, EXCIPIENTES, ETC.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662366517P | 2016-07-25 | 2016-07-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019000198A1 true CL2019000198A1 (es) | 2019-05-31 |
Family
ID=61017335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019000198A CL2019000198A1 (es) | 2016-07-25 | 2019-01-25 | Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración. |
Country Status (12)
Country | Link |
---|---|
US (3) | US20190183850A1 (es) |
EP (1) | EP3487482A4 (es) |
CN (1) | CN109789095A (es) |
AU (1) | AU2017302559A1 (es) |
BR (1) | BR112019001528A8 (es) |
CA (1) | CA3031533A1 (es) |
CL (1) | CL2019000198A1 (es) |
CO (1) | CO2019000787A2 (es) |
IL (1) | IL264386B2 (es) |
MX (1) | MX2019001121A (es) |
PE (1) | PE20200478A1 (es) |
WO (1) | WO2018022669A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3755309A1 (en) * | 2018-02-23 | 2020-12-30 | Columbia Care LLC | Hard-pressed scored splittable marijuana tablets |
WO2019211772A1 (en) * | 2018-05-03 | 2019-11-07 | Radient Technologies Inc. | Obtaining extracts in a solid form |
WO2020092352A1 (en) * | 2018-10-30 | 2020-05-07 | Kelsie Biotech, Llc | Tablets, formulations and methods for low melting point active ingredients |
US20220023220A1 (en) * | 2019-01-10 | 2022-01-27 | Columbia Care Llc | Rapidly disintegrating oral tablet |
US10925853B2 (en) | 2019-04-17 | 2021-02-23 | Nordiccan A/S | Oral cannabinoid tablet |
CA3040547C (en) | 2019-04-17 | 2021-12-07 | Medcan Pharma A/S | Cannabinoid lozenge formulation |
US11633351B2 (en) | 2019-12-13 | 2023-04-25 | Nordiccan A/S | Fast disintegrating cannabinoid tablets |
EP4087547A1 (en) * | 2020-01-08 | 2022-11-16 | Société des Produits Nestlé S.A. | Oral solid cannabinoid oil composition for treating gastrointestinal disorders |
EP4340644A1 (en) * | 2021-05-21 | 2024-03-27 | SWM Luxembourg | Process for incorporating additives into aerosol-producing substrates and products made therefrom |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991016882A1 (en) * | 1990-05-08 | 1991-11-14 | Liposome Technology, Inc. | Direct spray-dried drug/lipid powder composition |
JP2001507701A (ja) * | 1996-12-31 | 2001-06-12 | インヘイル・セラピューティック・システムズ・インコーポレーテッド | 親水性賦形剤を有する疎水性薬剤の溶液を噴霧乾燥するための方法及びその方法によって作製された組成物 |
DE10296335T5 (de) * | 2001-02-14 | 2004-04-15 | G W Pharma Ltd., Salisbury | Pharmazeutische Formulierungen |
US6730330B2 (en) * | 2001-02-14 | 2004-05-04 | Gw Pharma Limited | Pharmaceutical formulations |
PA8576201A1 (es) * | 2002-07-10 | 2004-05-26 | Pfizer Prod Inc | Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco |
CA2664311C (en) * | 2006-09-15 | 2015-08-18 | Echo Pharmaceuticals B.V. | Granulate containing a pharmaceutically active substance and method for its manufacture |
CN101810593B (zh) * | 2010-05-10 | 2012-07-18 | 谢恬 | 一种榄香烯缓释片 |
AU2015292915B2 (en) * | 2014-07-21 | 2020-10-15 | Pharmaceutical Productions, Inc. | Solid dosage form composition for buccal or sublingual administration of cannabinoids |
US20180303791A1 (en) * | 2014-11-26 | 2018-10-25 | One World Cannabis Ltd | Synergistic use of cannabis for treating multiple myeloma |
US10172786B2 (en) * | 2014-12-16 | 2019-01-08 | Axim Biotechnologies, Inc. | Oral care composition comprising cannabinoids |
-
2017
- 2017-07-25 PE PE2019000259A patent/PE20200478A1/es unknown
- 2017-07-25 MX MX2019001121A patent/MX2019001121A/es unknown
- 2017-07-25 EP EP17835148.2A patent/EP3487482A4/en active Pending
- 2017-07-25 BR BR112019001528A patent/BR112019001528A8/pt not_active Application Discontinuation
- 2017-07-25 US US16/320,557 patent/US20190183850A1/en not_active Abandoned
- 2017-07-25 AU AU2017302559A patent/AU2017302559A1/en not_active Abandoned
- 2017-07-25 WO PCT/US2017/043808 patent/WO2018022669A1/en unknown
- 2017-07-25 CA CA3031533A patent/CA3031533A1/en active Pending
- 2017-07-25 CN CN201780058464.XA patent/CN109789095A/zh active Pending
-
2019
- 2019-01-21 IL IL264386A patent/IL264386B2/en unknown
- 2019-01-25 CL CL2019000198A patent/CL2019000198A1/es unknown
- 2019-01-28 CO CONC2019/0000787A patent/CO2019000787A2/es unknown
-
2020
- 2020-12-16 US US17/123,866 patent/US20210100771A1/en not_active Abandoned
-
2022
- 2022-06-15 US US17/841,456 patent/US20220323403A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20190183850A1 (en) | 2019-06-20 |
MX2019001121A (es) | 2019-10-21 |
BR112019001528A2 (pt) | 2019-06-18 |
EP3487482A1 (en) | 2019-05-29 |
CO2019000787A2 (es) | 2019-04-30 |
EP3487482A4 (en) | 2020-03-04 |
IL264386A (en) | 2019-02-28 |
PE20200478A1 (es) | 2020-03-03 |
IL264386B1 (en) | 2023-04-01 |
IL264386B2 (en) | 2023-08-01 |
WO2018022669A1 (en) | 2018-02-01 |
CN109789095A (zh) | 2019-05-21 |
CA3031533A1 (en) | 2018-02-01 |
AU2017302559A1 (en) | 2019-02-07 |
BR112019001528A8 (pt) | 2019-07-09 |
US20210100771A1 (en) | 2021-04-08 |
US20220323403A1 (en) | 2022-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019000198A1 (es) | Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración. | |
BR112017018276A2 (pt) | ?composição que compreende peptidase e biotensoativo e seu uso? | |
CO2018006662A2 (es) | Agonistas del receptor de apelina y métodos de uso | |
CL2017002335A1 (es) | Composiciones de cosmetica topica para combatir radicales libres | |
CL2020000632A1 (es) | Composición y método para el tratamiento del autismo. | |
CL2018000953A1 (es) | 2,4-dihidroxi-nicotinamidas como agonistas del receptor de apelina (apj) | |
CL2017002998A1 (es) | Plantas que tienen expresión modificada de thca sintasa | |
CL2016002877A1 (es) | Compuestos de 2-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y métodos de uso de los mismos. | |
CL2018003135A1 (es) | Derivados aromáticos de sulfonamida. | |
CL2016000508A1 (es) | Compuestos derivados de (2-metil-3-fenilfenil)metoxi sustituidos, inhibidores de la interacción pd-1/proteína pd-l1/proteína; composición farmacéutica que los comprende; y su uso para tratar una enfermedad infecciosa o cáncer. | |
CL2016002772A1 (es) | Composiciones de insulina de rápida acción | |
CR20180563A (es) | Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que lo contienen | |
UY36705A (es) | Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj | |
BR112017006137A2 (pt) | formulação que contém biotensoativo | |
CR20170425A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
BR112016012146A8 (pt) | derivados de aminopiridina como inibidores de quinase da família tam | |
DOP2016000226A (es) | Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados | |
MX2016014509A (es) | Formulacion de vitamina soluble en grasa. | |
SV2017005466A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
UY38031A (es) | Hidroxiisoxazolinas y derivados de estos | |
PE20200223A1 (es) | Una composicion bioestimulante a base de taninos y/o sus derivados, para el tratamiento de plantas cultivadas y/o partes de las mismas | |
PE20200338A1 (es) | Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil | |
CL2015003584A1 (es) | Compuestos nuevos para el tratamiento del cáncer. | |
ECSP22012650A (es) | Composiciones que comprenden tigolaner para el control de parásitos | |
BR112017018618A2 (pt) | odorizante de osmanthus |